Cordelia Persen/flickrOne in ten Namibian infants with HIV had tenofovir resistance and one in six had resistance to abacavir before starting treatment, while two-thirds had resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI). The study investigators say the level of resistance to tenofovir is the highest observed in any country study to date and highlights the need to accelerate access to alternative antiretroviral regimens for young children.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.